AMANDA ALLEN: Open Payments
NPI 1760949713 · BRYANT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 45 payments from 14 companies in 2025. Trend: 2023 $367 · 2024 $768 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $238 |
| Madrigal Pharmaceuticals | 3 | $72 |
| Lilly USA, LLC | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Janssen Biotech, Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 4 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $17 |
Products named: RINVOQ, REZDIFFRA, OMVOH, CREON, LINZESS, TREMFYA, VOQUEZNA, XIFAXAN.
Industry payments across AR — which companies pay providers there.
